These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Toward the emergence of nanoneurosurgery: part II--nanomedicine: diagnostics and imaging at the nanoscale level. Leary SP; Liu CY; Apuzzo ML Neurosurgery; 2006 May; 58(5):805-23; discussion 805-23. PubMed ID: 16639314 [TBL] [Abstract][Full Text] [Related]
28. The coming era of nanomedicine. Allhoff F Am J Bioeth; 2009 Oct; 9(10):3-11. PubMed ID: 19998074 [TBL] [Abstract][Full Text] [Related]
29. Nano/Microscale motors: biomedical opportunities and challenges. Wang J; Gao W ACS Nano; 2012 Jul; 6(7):5745-51. PubMed ID: 22770233 [TBL] [Abstract][Full Text] [Related]
30. Nanomedicine-based strategies for treatment of atherosclerosis. Schiener M; Hossann M; Viola JR; Ortega-Gomez A; Weber C; Lauber K; Lindner LH; Soehnlein O Trends Mol Med; 2014 May; 20(5):271-81. PubMed ID: 24594264 [TBL] [Abstract][Full Text] [Related]
31. Delivery of nano-objects to functional sub-domains of healthy and failing cardiac myocytes. Lukyanenko V Nanomedicine (Lond); 2007 Dec; 2(6):831-46. PubMed ID: 18095849 [TBL] [Abstract][Full Text] [Related]
32. Supramolecular nanodevices: from design validation to theranostic nanomedicine. Cabral H; Nishiyama N; Kataoka K Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933 [TBL] [Abstract][Full Text] [Related]
33. Nanomedicine in cardiovascular therapy: recent advancements. Binsalamah ZM; Paul A; Prakash S; Shum-Tim D Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):805-15. PubMed ID: 22894635 [TBL] [Abstract][Full Text] [Related]
34. Toward the emergence of nanoneurosurgery: part III--nanomedicine: targeted nanotherapy, nanosurgery, and progress toward the realization of nanoneurosurgery. Leary SP; Liu CY; Apuzzo ML Neurosurgery; 2006 Jun; 58(6):1009-26; discussion 1009-26. PubMed ID: 16723880 [TBL] [Abstract][Full Text] [Related]
35. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882 [TBL] [Abstract][Full Text] [Related]
36. Nanomedicine: novel approaches in human and veterinary therapeutics. Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101 [TBL] [Abstract][Full Text] [Related]
37. Cancer nanomedicine: from drug delivery to imaging. Chow EK; Ho D Sci Transl Med; 2013 Dec; 5(216):216rv4. PubMed ID: 24353161 [TBL] [Abstract][Full Text] [Related]
38. The emerging applications of magnetic nanovectors in nanomedicine. Seeney CE Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567 [TBL] [Abstract][Full Text] [Related]
39. Review: nanoparticles in drug delivery for the treatment of cancer. Arayne MS; Sultana N Pak J Pharm Sci; 2006 Jul; 19(3):258-68. PubMed ID: 16935836 [TBL] [Abstract][Full Text] [Related]
40. Nanomedicines: addressing the scientific and regulatory gap. Tinkle S; McNeil SE; Mühlebach S; Bawa R; Borchard G; Barenholz YC; Tamarkin L; Desai N Ann N Y Acad Sci; 2014 Apr; 1313():35-56. PubMed ID: 24673240 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]